Overview

Tranexamic Acid in Nasal Mohs Reconstruction

Status:
Recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.

Phase:

Phase 2

Details

Lead Sponsor:

Vanderbilt University Medical Center

Treatments:

Epinephrine
Epinephryl borate
Lidocaine
Racepinephrine
Tranexamic Acid